Spineway S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALSPW.PA research report →
About the company
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products.
- CEO
- Stéphane Le Roux
- IPO
- 2013
- HQ
- Ecully, FR
Price Chart
- Market Cap
- $103.62K
- P/E
- -1.92
- P/S
- 0.01
- P/B
- 0.19
- EV/EBITDA
- 1.38
- Div Yield
- 0.00%
- Gross Margin
- 26.31%
- Op Margin
- -17.16%
- Net Margin
- -18.00%
- ROE
- -9.54%
- ROIC
- -7.99%
- Revenue
- $12.43M · 4.02%
- Net Income
- $-2,238,000 · 42.01%
- EPS
- $-0.06 · 51.54%
- Op Income
- $-2,133,000
- FCF YoY
- 100.00%
- 52W High
- $0.26
- 52W Low
- $0.10
- 50D MA
- $0.14
- 200D MA
- $0.15
- Beta
- 0.19
- Avg Volume
- 110.22K
Get TickerSpark's AI analysis on ALSPW.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALSPW.PA coverage
Recent articles, reports, and earnings notes.
No research on ALSPW.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALSPW.PA report →Similar companies
Peers in the same neighborhood.